Social Profile: PCYC (Pharmacyclics)

tradingview via Twitter 10:00 PM  05/19/13 reply  |  re-tweet

$PCYC (Msgs, Twts) chart by beanz744: http://t.co/DiefBvL5cb LONG add-on.

dsobek via Twitter 08:14 PM  05/19/13 reply  |  re-tweet

@JWCPhD The only ones that could justify that price would be $ONXX (Msgs, Twts) or $PCYC (Msgs, Twts) and I am not sure either wants to be bought.

walktothecabin via Twitter 07:59 PM  05/19/13 reply  |  re-tweet

$PGNX (Msgs, Twts), $INSM (Msgs, Twts), $ISIS (Msgs, Twts) - a few pharma/biotechs I like - $PCYC (Msgs, Twts) and $AMGN (Msgs, Twts) might be bull flagging

olddoggnewtrix via Twitter 10:01 PM  05/18/13 reply  |  re-tweet

@bradloncar 3-5 years out I think $ECYT (Msgs, Twts) could be another $PCYC (Msgs, Twts)

TARBIOTECH via Twitter 04:24 PM  05/18/13 reply  |  re-tweet

Portfolio update on webpage w/notes and new "music therapy"pg. $PCYC (Msgs, Twts) $GILD (Msgs, Twts) $INCY (Msgs, Twts)

riverstonecap via Twitter 12:57 PM  05/18/13 reply  |  re-tweet

$GILD (Msgs, Twts)'s Idelalisib vs $PCYC (Msgs, Twts)'s Ibrutinib --- its no contest. winner is $PCYC (Msgs, Twts).

TrustTheFund via Twitter 05:38 PM  05/17/13 reply  |  re-tweet

liquidated $WFM (Msgs, Twts),...+18.5%....don't be greedy! Current price targets: $NBL (Msgs, Twts) 139, $PCYC (Msgs, Twts) 95, $VRNG (Msgs, Twts) 6, $CHL (Msgs, Twts) 65, $VIAB (Msgs, Twts) 79.

SPXKnight via Twitter 04:03 PM  05/17/13 reply  |  re-tweet

I am bullish two biotech tickers at the moment: $PCYC (Msgs, Twts) and $ACHN (Msgs, Twts). I will post charts later, but in short, both will retest their highs soon.

HalfBloodPope via Twitter 03:09 PM  05/17/13 reply  |  re-tweet

$PCYC (Msgs, Twts) to 140, put that in your pipe and smoke it.

ethan780 via Twitter 02:06 PM  05/17/13 reply  |  re-tweet

RT @AndyBiotech: $CELG (Msgs, Twts) Expects additional early stage BD deals in '13. Both $PCYC (Msgs, Twts) & $CELG (Msgs, Twts) mgnt were very enthusiastic about Revlimid/ibrutinib combo studies.

AndyBiotech via Twitter 01:59 PM  05/17/13 reply  |  re-tweet

$CELG (Msgs, Twts) Expects additional early stage BD deals in '13. Both $PCYC (Msgs, Twts) & $CELG (Msgs, Twts) mgnt were very enthusiastic about Revlimid/ibrutinib combo studies.

scientre via Twitter 01:25 PM  05/17/13 reply  |  re-tweet

MT @lifescivc: Sadly, long list T @zDonShimoda List of PI3k posters #ASCO13/Lugano $INFI (Msgs, Twts) $GILD (Msgs, Twts) $TGTX (Msgs, Twts) $NVS (Msgs, Twts) $PCYC (Msgs, Twts) etc http://t.co/FsBKAEiA1t

ColfaxCapital via Twitter 08:29 AM  05/17/13 reply  |  re-tweet

@LombardCapital cuz everyone bought in the 40s expecting a $PCYC (Msgs, Twts) like price

MogulAzam via Twitter 07:00 AM  05/17/13 reply  |  re-tweet

RT @LifeSciVC: Sadly, a long list RT @zDonShimoda: List of PI3k posters for ASCO13/Lugano $INFI (Msgs, Twts) $GILD (Msgs, Twts) $TGTX (Msgs, Twts) $NVS (Msgs, Twts) $PCYC (Msgs, Twts) etc (cont) http://t.co/c2fsDj8UCm

LifeSciVC via Twitter 05:57 AM  05/17/13 reply  |  re-tweet

Sadly, a long list RT @zDonShimoda: List of PI3k posters for ASCO13/Lugano $INFI (Msgs, Twts) $GILD (Msgs, Twts) $TGTX (Msgs, Twts) $NVS (Msgs, Twts) $PCYC (Msgs, Twts) etc (cont) http://t.co/c2fsDj8UCm